Author

S. Stelz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

C. Werlein· 1 shared D. Jonigk· 1 shared G. F. Rimmelzwaan· 1 shared H. Elbahesh· 1 shared M. Busch· 1 shared M. P. Kuehnel· 1 shared R. Meineke· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

C. Werlein

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Ex Vivo Validation of Six FDA-Approved Non-Receptor Tyrosine Kinase Inhibitors (NRTKIs) as Antivirals to Pandemic and Seasonal Influenza A Viruses

R. Meineke, S. Stelz, M. Busch, C. Werlein, M. P. Kuehnel, D. Jonigk, G. F. Rimmelzwaan, H. Elbahesh

The paper tests six FDA-approved non-receptor tyrosine kinase inhibitors for antiviral activity against influenza A viruses in cell cultures and human lung slices, finding potent inhibition of virus replication.

bioRxiv · Jan 19, 2022 · PreprintMicrobiology